Results 221 to 230 of about 753,590 (330)

Role of N6-methyladenosine RNA modification in cancer. [PDF]

MedComm (2020)
Qu Y, Gao N, Zhang S, Gao L, He B, Wang C, Gong C, Shi Q, Li Z, Yang S, Xiao Y.   +10 more
europepmc   +1 more source

Synthesis and physical and physiological properties of 4'-thioRNA: application to post-modification of RNA aptamer toward NF- B [PDF]

, 2004
Shuichi Hoshika
openalex   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Epigenetic Mechanisms in Osteoporosis: Exploring the Power of m⁶A RNA Modification. [PDF]

J Cell Mol Med
Tian S, Song Y, Guo L, Zhao H, Bai M, Miao M.   +5 more
europepmc   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

Functional organization of box C/D RNA-guided RNA methyltransferase [PDF]

, 2020
Huang, Lin, Lilley, David M. J., Wang, Jiayin, Yang, Zuxiao, Ye, Keqiong   +4 more
core   +2 more sources

RNA modification in normal hematopoiesis and hematologic malignancies. [PDF]

MedComm (2020)
Chen X, Yuan Y, Zhou F, Li L, Pu J, Jiang X.   +5 more
europepmc   +1 more source

Transglycosylation: A mechanism for RNA modification (and editing?) [PDF]

, 2005
George A. Garcia, Jeffrey D. Kittendorf
openalex   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

RNA modification regulators as promising biomarkers in gynecological cancers. [PDF]

Cell Biol Toxicol
Qi Y, Li T, Zhou Y, Hao Y, Zhang J.
europepmc   +1 more source